Guarini A - Search Results

1

Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases.

Soscia R, Della Starza I, De Novi LA, Ilari C, Ansuinelli M, Cavalli M, Bellomarino V, Cafforio L, Di Trani M, Cazzaniga G, Fazio G, Santoro A, Salemi D, Spinelli O, Tosi M, Terragna C, Robustelli V, Bellissimo T, Colafigli G, Breccia M, Chiaretti S, Di Rocco A, Martelli M, Guarini A, Del Giudice I, Foà R. Soscia R, et al. Among authors: guarini a. Hematol Oncol. 2023 Feb;41(1):50-60. doi: 10.1002/hon.3087. Epub 2022 Oct 19. Hematol Oncol. 2023. PMID: 36251440

2

Interleukin 2 in the management of hematologic malignancies.

Foà R, Meloni G, Guarini A, Vignetti M, Mandelli F, Gavosto F. Foà R, et al. Among authors: guarini a. Pharmacol Res. 1992 Sep;26 Suppl 2:82-3. doi: 10.1016/1043-6618(92)90610-n. Pharmacol Res. 1992. PMID: 1409333 No abstract available.

3

Has IL2 a role in the management of minimal residual disease for acute leukemia?

Foa R, Meloni G, Guarini A, Mandelli F, Gavosto F. Foa R, et al. Among authors: guarini a. Leukemia. 1992 Nov;6 Suppl 4:92-4. Leukemia. 1992. PMID: 1434844 Review.

4

IL2 treatment for cancer: from biology to gene therapy.

Foa R, Guarini A, Gansbacher B. Foa R, et al. Among authors: guarini a. Br J Cancer. 1992 Dec;66(6):992-8. doi: 10.1038/bjc.1992.400. Br J Cancer. 1992. PMID: 1457368 Free PMC article. Review.

5

Cytotoxic effectors activated by low-dose IL-2 plus IL-12 lyse IL-2-resistant autologous acute myeloid leukaemia blasts.

Vitale A, Guarini A, Latagliata R, Cignetti A, Foa R. Vitale A, et al. Among authors: guarini a. Br J Haematol. 1998 Apr;101(1):150-7. doi: 10.1046/j.1365-2141.1998.00645.x. Br J Haematol. 1998. PMID: 9576195 Free article.

6

Biotechnologies in haematological malignancies.

Foà R, Reato G, Guarini A. Foà R, et al. Among authors: guarini a. Forum (Genova). 1999 Jul-Dec;9(3 Suppl 3):54-8. Forum (Genova). 1999. PMID: 10607847

7

Phenotypic and functional characterization of the host immune compartment of chronic myeloid leukaemia patients in complete haematological remission.

Guarini A, Breccia M, Montefusco E, Petti MC, Zepparoni A, Vitale A, Foa R. Guarini A, et al. Br J Haematol. 2001 Apr;113(1):136-42. doi: 10.1046/j.1365-2141.2001.02724.x. Br J Haematol. 2001. PMID: 11328293 Free article.

8

Developmental approaches in immunological control of acute myelogenous leukaemia.

Torelli GF, Orsini E, Guarini A, Kell J, Foà R. Torelli GF, et al. Among authors: guarini a. Best Pract Res Clin Haematol. 2001 Mar;14(1):189-209. doi: 10.1053/beha.2000.0123. Best Pract Res Clin Haematol. 2001. PMID: 11355931 Review.

9

Accessory cells, cytokine loops and cell-to-cell interactions in chronic lymphocytic leukemia.

Orsini E, Guarini A, Foa R. Orsini E, et al. Among authors: guarini a. Rev Clin Exp Hematol. 2000 Mar;4(1):73-98. doi: 10.1046/j.1468-0734.2000.00004.x. Rev Clin Exp Hematol. 2000. PMID: 11486331 Review.

10

Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission.

Torelli GF, Guarini A, Palmieri G, Breccia M, Vitale A, Santoni A, Foa R. Torelli GF, et al. Among authors: guarini a. Br J Haematol. 2002 Feb;116(2):299-307. Br J Haematol. 2002. PMID: 11841430 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

447 results

Search Page